Lionel Resnick
- Virology top 0.2%
- Infectious Diseases top 0.5%
- Epidemiology top 2%
- Oncology top 2%
- Molecular Biology top 10%
- Co-authors
- Paul ShapshakWallace W. TourtellotteDavid D. HoJerome E. GroopmanHerbert WeissbachNancy Raab‐TraubNathan BrotT R Rota
- Topics
- HIV Research and Treatment (31 papers)HIV/AIDS drug development and treatment (21 papers)T-cell and Retrovirus Studies (14 papers)
- Cited by
- VirologyInfectious DiseasesNeurology
- Partner nations
- United StatesJapanGermany
In The Last Decade
Lionel Resnick
73 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Virology 2.4k
- Infectious Diseases 2.1k
- Epidemiology 1.3k
- Oncology 1.0k
- Molecular Biology 946
Countries citing papers authored by Lionel Resnick
This map shows the geographic impact of Lionel Resnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lionel Resnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lionel Resnick more than expected).
Fields of papers citing papers by Lionel Resnick
This network shows the impact of papers produced by Lionel Resnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lionel Resnick. The network helps show where Lionel Resnick may publish in the future.
Co-authorship network of co-authors of Lionel Resnick
This figure shows the co-authorship network connecting the top 25 collaborators of Lionel Resnick. A scholar is included among the top collaborators of Lionel Resnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lionel Resnick. Lionel Resnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 14 | |
| 3 | 7 | |
| 4 | 105 | |
| 5 | 40 | |
| 6 | 10 | |
| 7 | 458 | |
| 8 | 11 | |
| 9 | A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. | 64 |
| 10 | 17 | |
| 11 | 6 | |
| 12 | 4 | |
| 13 | 178 | |
| 14 | 7 | |
| 15 | 39 | |
| 16 | 12 | |
| 17 | 89 | |
| 18 | 77 | |
| 19 | 8 | |
| 20 | 43 |
About Lionel Resnick
Lionel Resnick is a scholar working on Virology, Infectious Diseases and Microbiology, having authored 74 papers that have together received 5.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (31 papers), HIV/AIDS drug development and treatment (21 papers) and T-cell and Retrovirus Studies (14 papers). The work is most often cited by research in Virology (2.4k citations), Infectious Diseases (2.1k citations) and Neurology (447 citations). Lionel Resnick has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Paul Shapshak, Wallace W. Tourtellotte, David D. Ho, Jerome E. Groopman, Herbert Weissbach, Nancy Raab‐Traub, Nathan Brot, T R Rota, J. Davis Allan and Robert T. Schooley. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.